Methicillin-resistant Staphylococcus aureus, better known as MRSA, remains one of the most formidable adversaries in modern medicine, killing more than 100,000 people each year and ranking as the single bacterial pathogen with the highest attributable mortality in the context of antimicrobial resistance. Now, a team of researchers at Al-Nahrain University in Baghdad, working with collaborators at Universiti Pendidikan Sultan Idris in Malaysia, has reported a new twist in the fight against this superbug: zinc oxide nanoparticles synthesised using nothing more exotic than the leaves of a common shrub, Dodonaea viscosa, can not only kill MRSA but also silence the very genes the bacterium uses to latch onto human tissue. The study, published in International Microbiology, offers a rare combination of direct antibacterial potency and anti-virulence activity, a dual action that could help slow the relentless march of resistance.
The choice of plant was no accident. Dodonaea viscosa, a perennial shrub widespread across tropical and subtropical regions including Iraq, is rich in flavonoids, saponins, alkaloids, and reducing sugars. The researchers collected fresh leaves from the university campus gardens, dried and ground them, and prepared three different extracts using water, 70 percent ethanol, and 70 percent hexane. Gas chromatography-mass spectrometry revealed that the aqueous extract was dominated by D-Fructose-3-O-methyl, which accounted for 37.62 percent of the identified fraction. This methylated sugar, with its abundance of hydroxyl groups capable of coordinating zinc ions, proved ideal as both a bioreducing and stabilising agent. Water was also the safest and most biocompatible solvent, avoiding the organic residues that might complicate downstream biological applications.
The synthesis itself was strikingly simple. Fifteen grams of zinc chloride were added to 300 millilitres of freshly prepared aqueous leaf extract, stirred in the dark for 45 minutes, and centrifuged to collect the precipitate, which was washed with ethanol and dried at around 40 degrees Celsius. A visible colour change signalled that something had happened at the nanoscale, and a battery of analytical techniques confirmed it. Ultraviolet-visible spectroscopy showed a distinct absorption peak at 321 nanometres, squarely within the characteristic surface plasmon resonance range of 300 to 380 nanometres for zinc oxide nanoparticles. Fourier-transform infrared spectroscopy revealed a diagnostic zinc-oxygen stretching band at 619 inverse centimetres, alongside retained hydroxyl and carbon-hydrogen bands indicating that plant phytochemicals remained capping the particle surfaces, a hallmark of biogenic synthesis that enhances colloidal stability and biocompatibility.
Scanning electron microscopy showed granular to semi-spherical particles with some aggregation, a consequence of the high surface energy of zinc oxide and the cross-linking of phytochemicals during drying, with an estimated mean diameter of about 56 nanometres. Atomic force microscopy, which resolves individual particles with greater precision, counted 1,350 particles and produced a mean diameter of 34.95 nanometres, with most particles falling in the 20 to 60 nanometre window considered optimal for membrane penetration and reactive oxygen species generation. Energy-dispersive X-ray spectroscopy confirmed zinc at 28.94 percent and oxygen at 22.54 percent as the principal elements, with residual carbon attributable to the phytochemical coating and chlorine to the precursor salt. Notably, X-ray diffraction showed a broad background without sharp crystalline peaks, indicating low crystallinity or partial amorphous character, likely because the green synthesis omitted the high-temperature calcination step that normally drives zinc oxide into its hexagonal wurtzite structure, and because organic capping agents interfered with crystal growth.
The biological results were where the study truly distinguished itself. The test organism was a clinically isolated multidrug-resistant MRSA strain, designated 415-1, confirmed by the VITEK 2 automated system with 95 percent identification probability. Antimicrobial susceptibility testing showed resistance to 15 antibiotic agents spanning all beta-lactam classes, fluoroquinolones, aminoglycosides, chloramphenicol, tetracycline, and trimethoprim-sulfamethoxazole, a profile representative of community-associated MRSA circulating in Baghdad hospitals. Against this formidable isolate, the crude Dodonaea viscosa aqueous extract showed a minimum inhibitory concentration of 32.25 milligrams per millilitre. The green-synthesised zinc oxide nanoparticles achieved an MIC of 4.312 milligrams per millilitre, a 7.5-fold improvement that underscores the value of nanoformulation in amplifying the inherent antimicrobial potential of medicinal plant chemistry.
The mechanism behind this potency is fundamentally different from that of conventional antibiotics. Rather than attacking a single molecular target, zinc oxide nanoparticles deploy multiple simultaneous assaults: they release zinc ions that disrupt enzymatic activity and membrane integrity, generate hydrogen peroxide and superoxide radicals at the particle surface that inflict oxidative damage on DNA, lipids, and proteins, and physically interact with the bacterial cell wall through electrostatic forces. This multi-target engagement means that any single resistance mutation is far less likely to confer meaningful protection, a crucial advantage at a time when the pipeline of genuinely novel antibiotics against Gram-positive pathogens is dangerously thin. The measured MIC sits comfortably within the published range of 0.1 to 16 milligrams per millilitre for biogenically synthesised zinc oxide nanoparticles against S. aureus, with variation across studies reflecting differences in particle size, crystallinity, surface charge, and assay methodology.
Perhaps the most clinically significant findings emerged at concentrations below the MIC, where the nanoparticles did not kill the bacteria but fundamentally changed their behaviour. In a crystal violet microplate biofilm assay, sub-MIC nanoparticle concentrations inhibited biofilm formation by 41 percent in one clinical isolate and 58 percent in another. This matters enormously because biofilm-embedded MRSA cells display antibiotic tolerance several hundred times greater than their free-floating counterparts, and biofilms on medical devices and tissue surfaces are a primary driver of persistent, recurrent infections. The variability between the two isolates likely reflects genuine strain heterogeneity in biofilm architecture, differences in accessory gene regulator operon type, surface protein expression, and polysaccharide production, and it suggests that patient-specific strain characterisation may eventually inform the clinical deployment of nanoparticle-based anti-biofilm strategies.
The anti-virulence dimension took the story a step further. Using reverse transcription quantitative PCR with the 2 to the power of negative delta delta Ct method and 16S ribosomal RNA as the reference gene, the researchers measured the expression of two adhesin-encoding virulence genes, fnbA and cna. The fnbA gene encodes fibronectin-binding protein A, a member of the MSCRAMM family that mediates adhesion to fibronectin-coated tissue surfaces and implanted medical devices, while cna encodes the collagen-binding adhesin that guides bacterial attachment to cartilage, bone, and cardiac valves and is linked to invasive diseases such as infective endocarditis and septic arthritis. Treatment with sub-MIC nanoparticles reduced fnbA expression to 0.37-fold of untreated controls, a 63.4 percent reduction, and cna expression to 0.46-fold, a 54.0 percent reduction. Melt curve analysis confirmed single-product amplification for all targets, and no-template controls showed no amplification.
The therapeutic logic of suppressing virulence rather than killing bacteria outright is compelling. Because sub-lethal nanoparticle concentrations leave cells viable and the virulence genes themselves unmutated, the treatment does not impose the lethal selective pressure that accelerates resistance acquisition. Bacteria exposed to the nanoparticles can recover full virulence gene expression once the particles are removed, meaning resistance is not directly selected for. The molecular pathway remains incompletely characterised, but sub-lethal zinc concentrations are known to interact with two-component signal transduction networks and the Agr and SarA quorum-sensing apparatus that govern virulence gene expression in S. aureus, and oxidative modification of regulatory proteins by sub-lethal reactive oxygen species is a plausible parallel route.
The authors are candid about the limitations of their work. The quantitative PCR dataset comprised only two treated and two untreated biological replicates, insufficient for formal statistical inference, and the 16S reference gene showed variation in its Ct values between groups, introducing possible normalisation error. Dynamic light scattering and zeta potential measurements were not performed, leaving colloidal stability under physiological conditions unassessed, and no cytotoxicity testing on mammalian cells was carried out, so no conclusions about safety toward human tissue can yet be drawn. The team calls for expansion to at least three biological replicates, RNA input equalisation, colloidal characterisation, and cytotoxicity profiling to define a therapeutic window before any in vivo translation. Even with these caveats, the study establishes Dodonaea viscosa as a viable bioreducing platform and positions its zinc oxide nanoparticles as candidates for anti-virulence-based management of MRSA, strengthening the growing concept that plant-derived metal oxide nanoparticles can serve as versatile antimicrobial systems with both bactericidal and pathogen-disarming capabilities, precisely the kind of mechanistically novel approach that the post-antibiotic era demands.
Subject of Research: Green-synthesised zinc oxide nanoparticles as antibacterial and anti-virulence agents against methicillin-resistant Staphylococcus aureus
Article Title: Dodonaea viscosa–mediated zinc oxide nanoparticles exhibit antibacterial, anti-biofilm, and anti-virulence activity against methicillin-resistant Staphylococcus aureus
Article References: Nasser, A., Alobaidi, K. H., & Al-Obaidi, J. R. (2026). Dodonaea viscosa–mediated zinc oxide nanoparticles exhibit antibacterial, anti-biofilm, and anti-virulence activity against methicillin-resistant Staphylococcus aureus. International Microbiology. https://doi.org/10.1007/s10123-026-00874-5
Image Credits: AI Generated
DOI: 10.1007/s10123-026-00874-5
Keywords: MRSA, zinc oxide nanoparticles, Dodonaea viscosa, green synthesis, anti-virulence, biofilm, antimicrobial resistance, fnbA, cna, RT-qPCR, multidrug resistance, nanomedicine
Cite Scienmag News
APA MLA Chicago
Copy citation Download RIS
Tags: anti-virulenceanti-virulence therapyAntimicrobial Resistancebacterial gene silencingbiofilmcnaDodonaea viscosaDodonaea viscosa extractdual-action antibacterial agentsfnbAgreen synthesisMRSAmultidrug resistanceNanomedicinenanoparticle synthesisnatural antimicrobial agentsphytochemicals in infection controlplant-based nanoparticlesRT-qPCRsuperbug controlzinc oxide nanoparticles
